Diagnostic Solutions grew modestly as strength in Lab Automation and momentum in BD MAX molecular platform IVD assays was partially offset by respiratory season timing. Q1 performance also ...

Connected Care includes BD’s Medication Management Solutions and Advanced Patient Monitoring businesses with smart devices that use automation, artificial intelligence, and analytics.

Chipsee has introduced three new panel PCs powered by the Raspberry Pi Compute Module 5 (CM5), namely the EPC-CM5-070, ...

Becton, Dickinson and Company (BDX, Financials) announced a major strategic shift with plans to separate its Biosciences and Diagnostic Solutions unit, aiming to create two independent ...

Becton Dickinson plans to break off its biosciences and diagnostic solutions business and focus on the medtech sector. The company said late Wednesday the split could take the form of a sale ...

Revenue: US$5.17b (up 9.8% from 1Q 2024). Net income: US$303.0m (up 7.8% from 1Q 2024). Profit margin: 5.9% (down from 6.0% in 1Q 2024). EPS: US$1.05 (up from US$0.97 in 1Q 2024). Revenue exceeded ...

Becton Dickinson BDX1.16%increase; green up pointing triangle and Co. said it plans to break off its bioscience and diagnostic solutions business to focus on medical technology. Chief Executive ...

American medical technology (MedTech) company Becton Dickinson (BDX) plans to split from its bioscience and diagnostic solutions arms to become a leaner and more focused company. The news was anno ...

Becton Dickinson shares have climbed 8% since the beginning of the year, while the S&P’s 500 index has increased 27%. In the final minutes of trading on Wednesday, shares hit $245.06, a rise of ...

Piper Sandler analyst Jason Bednar maintained a Buy rating on Becton Dickinson (BDX – Research Report) today and set a price target of $280.00. The company’s shares closed yesterday at $227.21.

Lacrosse has experienced significant growth in popularity worldwide and will return to the Summer Olympic Games in 2028.